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ablate the refluxing vein in a minimally invasive way. 
nevertheless, tumescent anesthesia is required, leading 
to possible patient discomfort, occasional hematomas 
and to extremely rare but serious complications such as 
fiber fracture.6, 7
recently, an innovative holmium laser (Hol) has 
been introduced to the market, offering the consistent 
advantage of not requiring tumescent anesthesia. This 
device is able to reduce the great saphenous vein (gSV) 
caliber, allowing immediate, subsequent foam sclero-
therapy, even in the largest veins. The strategy is known 
endovenous thermal ablation has become a mainstay in the treatment of saphenous reflux 1 and is rec-
ommended as the best treatment option by international 
guidelines.2, 3 So far, the main thermal sources for endo-
venous ablation are radiofrequency ablation (rFa) and 
endovenous laser ablation (EVLA).4, 5 they are cur-
rently preferred over surgery, because they are safe and 
minimally invasive.2, 3
By introducing a fiber into the saphenous vein, ther-
mal energy is delivered intra-luminally and absorbed by 
blood and vein wall. The aim of these techniques is to 
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BACKGROUND: A new holmium laser (HOL) has been introduced to the market. The device is able to reduce the great saphenous vein (GSV) 
caliber in a tumescence-free procedure, favoring an effective sclerotherapy of large vessels. Aim of the present investigation is to provide the 
first in vivo data about the effect of HOL on GSV histology.
METHODS: Six chronic venous disease (C2-5, ep, as, Pr) patients (M:F ratio 1:1; age: 57±8, BMI 24±2 kg/m2) underwent HOL-assisted caliber 
reduction of the GSV, high-ligation and flush ligation of the incompetent tributaries. Three cm of proximal great saphenous vein not treated by 
laser and 3 cm of a contiguous segment that was just previously treated by HOL were harvested.
Histological assessments were performed. Patent GSV lumen caliber was assessed at the mid-thigh right before, and after the procedure. Peripro-
cedural pain was graded by Visual Analogue Scale.
RESULTS: GSV samples after holmium laser therapy showed thickening of the vascular wall with a decreased, yet patent lumen. Immunos-
taining demonstrated intact endothelial lining in both the treated and not treated segments. Expansion of collagen fibers was observed in the 
laser-treated segments. Collagen appeared more homogeneous than in controls, with an amorphous appearance. Laser treated veins showed a 
reduction in elastic fibers with greater fragmentation. Smooth muscle cells appeared swollen. The caliber of the mid-thigh great saphenous vein 
lumen decreased from 8.1±0.8 mm to 3.9±0.2 mm (P<0.0001). The average periprocedural pain was 1±0.6.
CONCLUSIONS: HOL significantly reduces the caliber of the GSV. The endothelial lining is spared, while the remaining wall is thickened by 
a hyalinization-like process.
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orcein staining (a specific histochemical staining used 
to identify elastic fibers) and Masson trichrome stain-
ing (a histochemical staining used to identify collagen 
fibers and muscle fibers).
Immunohistochemistry was also employed to verify 
the presence of factor VIII — which is normally ex-
pressed in endothelial cells — and of actin — which is 
normally expressed in smooth muscle cells.
Patent GSV lumen caliber was assessed at the mid-
thigh right before and after the procedure in the supine 
position.
Periprocedural HOL-induced pain was graded by 
Visual analogue Scale ranging from 0 (no pain) to 10 
(unbearable pain).15, 16
Statistical analysis
InStat GraphPad (GraphPad Software, Inc., La Jolla, 
CA, USA) was used for statistical analysis. The data 
were expressed as mean ± standard deviation. The nor-
mal distribution of the data was verified by the Kol-
mogorov-Smirnov test. The differences between vein 
diameters pre- and post-procedure were performed us-
ing two-tailed paired Student’s t-test. A P value of 0.05 
or less was considered statistically significant.
Results
All 6 harvested samples were suitable for histologi-
cal analysis. Gross examination of the GSV after HOL 
therapy showed a conspicuous thickening of the vascu-
lar wall with a decreased patent lumen (Figure 1).
On microscopic examination, the vascular wall 
showed sub-intimal fibrosis and hypertrophy of the 
smooth muscle coat in both Hol treated and not treated 
samples, because of the common chronic venous dis-
ease condition.
the endothelial lining remained intact in both groups, 
as demonstrated by factor VIII immunostaining (Fig-
ure 2). Various constituents of the vascular wall showed 
structural alterations. Compared to the contiguous GSV 
tract (Figure 3A) that was not previously shrunken, HOL 
samples demonstrated an expansion of the collagen fibers, 
with a more homogeneous hyalinization-like amorphous 
appearance and a loss of normal fibrillar characteristics 
(Figure 3B). In HOL treated samples, orcein staining 
demonstrated a significant reduction in elastic fibers with 
by the acronym laFoS (laser assisted Foam Sclero-
therapy).8 The specific effect of HOL is strictly related 
to the average lower temperature generated by the de-
vice in comparison to traditional rFa and eVla: 42 °C 
versus more than 100 °C, respectively.8-11
Endovenous thermal ablation techniques will likely 
continue to play a persistent major role among modern 
and future phlebology therapeutic options. Neverthe-
less, their mechanistic features on the venous histologic 
layers and the related biological effects are described 
just by a limited number of papers.12
the aim of the present morphologic investigation is 
to provide a detailed description of the effect of Hol 
on the venous wall that can be used as a basis for fu-
ture, deeper comprehension of the phenomena govern-
ing the action, and thus the performance of endovenous 
devices.
Materials and methods
Six chronic venous disease patients (M/F:1/1; 
age:57±8; BMI:24±2) (C2, 2 cases; C3, 2 cases; C4, 1 
case; C5, 1 case) (C2-5, Ep, As, Pr) underwent a single 
procedure that included a Hol assisted caliber reduc-
tion of the GSV from the groin downward, a sapheno-
femoral surgical high-ligation and a flush ligation of the 
incompetent saphenous tributaries along the leg. The 
HOL fiber (800 microns) was inserted directly into the 
GSV right above the knee by a 17-G needle. Neither a 
guide-wire nor tumescent anesthesia was used.
After positioning the device 3 cm below the sapheno-
femoral junction, HOL was used in short pulse mode 
(350 µs), delivering 300 mJ per pulse at a frequency of 
7 Hz for a total of 2.1 J/s. HOL was used in 3 repeated 
cycles of 2.5 s each, during which the fiber was kept in 
the same position, moving distally 1 cm after delivering 
16 J/cm.
Subsequently, a high ligation was performed at the 
groin under local anesthesia. During the high ligation, 
3 cm of proximal GSV not treated by HOL and 3 cm of 
the contiguous distal segment that was just previously 
treated by HOL were harvested.
all patients signed an informed consent prior to the 
procedure. Institutional Review Board approval was 
obtained.
For the histopathologic study, multiple sections of the 
samples were stained with standard ematoxylin-eosin, 
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Discussion
Hol is a device that has been on the market for more 
than a decade. Its main application has been in urology 
and orthopedics. Nowadays however, it is used in sev-
eral other specialties including general surgery, neuro-
surgery, dentistry and phlebology.8, 13, 14
It is a pulsed Ho:YAG laser that uses a wavelength of 
2100 nm, thus highly absorbed by water.15
In the phlebology setting, a Hol pulse lasts 350 µs 
and delivers from 100 to 500 mJ in cycles of 7 Hz, cre-
ating a peak temperature of 76 °C that is responsible for 
the shrinkage.
The average temperature never rises above 42 °C.
Until now, a limited number of histopathological 
evaluations have been performed on venous walls fol-
lowing EVLA and RFA treatments.16-19
great fragmentation. Loss of the normal weave was clear-
ly appreciated just in the HOL treated samples and not in 
the contiguous venous segment (Figure 4).
Actin immunostaining demonstrated significant 
swelling in the HOL samples that was not detected in 
the contiguous GSV segments (Figure 5).
After HOL shrinkage, thickening of the media was 
immediately detected by intraoperative sonographic 
scanning, together with a hyperechoic line at the bor-
der of the media and adventitia (Figure 6A). Even if 
shrunken, the venous lumen remained patent and, be-
fore the high-ligation, inhabited by a thoracic pump ac-
tivated flow (Figure 6B). Caliber of the patent mid-thigh 
GSV lumen decreased from 8.1±0.8 mm to 3.9±0.2 mm 
(P<0.0001) (Figure 6). The average periprocedural pain 
was 1±0.6.
Neither minor nor major complications were reported.
Figure 1.—Macroscopic comparative evaluation among GSV not treated 
by HL (A) and the GSV immediately below that was previously treated 
by HL (B, C). A clearly thickened wall is detected both at the harvesting 
(B) and after histological fixation (C).
Figure 2.—Brown staining (black arrow) of endothelial cells with factor 
VIII immunostaining after HL shrinkage of the GSV (4X).
Figure 3.—GSV tract not treated by HL (trichrome staining 2×) (3A) compared to the contiguous GSV segment treated by HL (trichrome staining 
2X)(3B). An expansion of the collagen fibers is clearly evident, in particular near the adventitia after the HL shrinkage (arrow, blue staining).
a B C
a B
                  COPYRIGHT© 2017 EDIZIONI MINERVA MEDICA 
Th
is
 d
oc
um
en
t i
s 
pr
ot
ec
te
d 
by
 in
te
rn
a
tio
na
l c
op
yr
ig
ht
 la
w
s.
N
o 
ad
di
tio
na
l r
ep
ro
du
ct
io
n 
is 
au
th
or
ize
d.
It 
is
 p
er
m
itt
ed
 fo
r 
pe
rs
on
al
 u
se
 to
 d
ow
n
lo
ad
 a
nd
 s
av
e
 o
n
ly 
on
e 
file
 a
nd
 p
rin
t o
nl
y 
on
e 
co
py
 o
f t
hi
s 
Ar
tic
le
.
It 
is
 n
ot
 p
er
m
itt
ed
 to
 m
ak
e
 a
dd
itio
na
l c
op
ie
s
(ei
the
r s
po
rad
ica
lly
 o
r s
ys
te
m
at
ica
lly
,
 
e
ith
er
 p
rin
te
d 
or
 e
le
ct
ro
ni
c) 
of 
the
 A
rtic
le
 fo
r 
a
ny
 p
ur
po
se
.
It 
is
 n
ot
 p
er
m
itt
ed
 to
 d
ist
rib
u
te
 th
e 
el
ec
tro
ni
c 
co
py
 o
f t
he
 a
rti
cl
e 
th
ro
ug
h 
on
lin
e 
in
te
rn
e
t a
nd
/o
r i
nt
ra
n
e
t f
ile
 s
ha
rin
g 
sy
st
em
s,
 
e
le
ct
ro
ni
c 
m
ai
lin
g 
or
 a
ny
 o
th
er
m
e
a
n
s 
w
hi
ch
 m
ay
 a
llo
w
 a
cc
e
ss
 to
 th
e 
Ar
tic
le
.
Th
e 
us
e 
of
 a
ll 
or
 a
ny
 p
ar
t o
f t
he
 A
rti
cl
e 
fo
r 
a
ny
 C
om
m
er
cia
l U
se
 is
 n
ot
 p
er
m
itt
ed
.T
he
 c
re
at
io
n 
of
 d
er
iva
tiv
e
 w
o
rk
s 
fro
m
 th
e 
Ar
tic
le
 is
 n
ot
 p
er
m
itt
ed
.T
he
 p
ro
du
ct
io
n 
of
 re
pr
in
ts
 fo
r 
pe
rs
on
al
 o
r c
om
m
er
cia
l u
se
 is
n
o
t p
er
m
itt
ed
.I
t i
s 
no
t p
er
m
itt
ed
 to
 re
m
ov
e,
 
co
ve
r,
 
ov
e
rla
y, 
o
bs
cu
re
,
 
bl
oc
k,
 o
r c
ha
ng
e 
an
y 
co
py
rig
ht
 n
ot
ice
s 
or
 te
rm
s 
o
f u
se
 w
hi
ch
 th
e 
Pu
bl
is
he
r m
ay
 p
os
t o
n 
th
e 
Ar
tic
le
.
It 
is
 n
ot
 p
er
m
itt
ed
 to
 fr
a
m
e
 o
r 
u
se
 fr
a
m
in
g 
te
ch
ni
qu
es
 to
 e
nc
lo
se
 a
ny
 tr
a
de
m
ar
k,
 lo
go
,
o
r 
o
th
er
 p
ro
pr
ie
ta
ry
 in
fo
rm
a
tio
n 
of
 th
e 
Pu
bl
is
he
r.
HolMIUM laSer In CVD treatMent gIaneSInI
Vol. 36 - No. 2 InternatIonal angIology 125
venous perforation that was higher in continuous rather 
than pulsed lasers: a phenomenon that was linked to the 
carbonization and significant heating of the fiber tip.20, 22
In contrast to rFa and eVla, the current investiga-
tion demonstrates that the lower temperature of HOL 
spares the endothelium.20, 21
the high temperature produced by eVla and rFa 
is associated with macroscopic induration of the vessel. 
Microscopic assessments have demonstrated endothe-
lial and media disintegration, smooth muscle cell swell-
ing and transmural thermal lesions.16, 17, 20, 21
Previous investigations have also reported a risk of 
Figure 4.—A) Normal representation of elastic fibers (orcein staining 4×) in the segment not treated by HL. B) Significant reduction in elastic fibers 
with fragmentation and loss of normal weave after HL use in contiguous GSV segment in the same patient (orcein staining 4×). A) GSV segment 
not treated by HL compared to the contiguous GSV tract that was previously treated by HL. B) Significant swelling of smooth muscle cells is dem-
onstrated after HL use by actin immunostaining (4×).
Figure 5.—A) GSV segment not treated by HL compared to the contiguous GSV tract that was previously treated by HL. B) Significant swelling of 
smooth muscle cells is demonstrated after HL use by Actin immunostaining (4X). 
a B
a B
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the Hol-induced vessel caliber reduction paves 
the way for more effective sclerotherapy, decreasing 
the risks linked to high sclerotherapy drug concentra-
tions.27, 28
Further investigations should assess the histopatho-
logical evolution of this brand new type of shrinkage 
over time, together with the eventual biological conse-
quences of an intact endothelium. The HOL-induced 
low temperature also brings the great advantage of a 
tumescent free and painless office-based procedure. 
Another benefit comes from patient feedback in the ab-
sence of any anesthesia, so providing a potential further 
reduction of the neurological and thermal complications 
that are already diminished by the significantly lower 
energy delivered by HOL.29
The saphenous-sparing strategies’ satisfying recur-
rence rate 30, 31 together with the mini-invasiveness of 
the modern endovenous techniques 32 have progres-
sively stimulated pioneering investigations regarding 
gSV competence restoration by means of endovenous 
devices.33-35
In this environment, HOL offers the chance to switch 
from an ablative tool, as in laFoS strategy, to a po-
tential means of GSV flow restoration without the need 
of any subsequent foam sclerotherapy. Further hemo-
dynamics investigations on this topic are currently on-
Collagen denatures between 50 °C and 60 °C.23
the circulating blood represents a fundamental factor 
in the process of wall cooling.
In fact, during the pulsed HL switched off phase, the 
endothelium is cooled by the thermal convection that is 
created by venous flow. Conversely, the media layer can 
only cool by conduction, a slower phenomenon that re-
quires more time than the same HL switched off phase.
For this reason, the media layer progressively reaches 
temperatures above 60 °C, leading to wall damage de-
spite the endothelium sparing.8, 20, 24
The present investigation demonstrates how, de-
spite mild thermal damage, the microscopic features 
of the media are similar to those detected after ef-
fective high temperature rFa and eVla: collagen 
denaturation, elastic fiber fragmentation, and smooth 
muscle cell swelling. At the same time, neither splits 
and gaps, nor wall perforations were reported in HOL 
samples.
like traditional endovenous thermal devices, Hol-
induced wall damage leads to a chronic rather than tran-
sitory process.
In the present investigation, a consequent lumen re-
duction was detected by intraoperative Doppler scan-
ning. The efficacy of foam sclerotherapy is limited by 
GSV caliber.25, 26
Figure 6.—A Venous wall thickening after HL shrinkage. A “double wall sign” is created by the appearance of the adventitia and the hyperechogenic 
line that is produced after HL use. A narrower but still patent lumen is clearly evident by color-Doppler investigation (B).
a B
Double wall sign
Media thickening
                 
lUMeng
SV Patent lumen
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DF, et al. Radiofrequency Endovenous ClosureFAST versus Laser 
Ablation for the Treatment of Great Saphenous Reflux: A Multicent-
er, Single-blinded, Randomized Study (RECOVERY Study). J Vasc 
Interv Radiol 2009;20:752-9.
10. van der Geld CW, van den Bos RR, van Ruijven PW, Nijsten T, 
Neumann HA, van Gemert MJ. The heat-pipe resembling action 
of boiling bubbles in endovenous laser ablation. Lasers Med Sci 
2010;25:907-9.
11. Malskat WS, Stokbroekx MA, van der Geld CW, Nijsten TE, van 
den Bos RR. Temperature profiles of 980- and 1,470-nm endovenous 
laser ablation, endovenous radiofrequency ablation Guess JJ. Endov-
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Phlebology 2014;19:45-8.
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RA, Bruijninckx CM, et al. Endovenous laser ablation (EVLA): a 
review of mechanisms, modeling outcomes, and issues for debate. 
Lasers Med Sci 2014;29:393-403.
13. Wollin TA, Denstedt JD. The holmium laser in urology. J Clin Laser 
Med Surg 1998;16:13-20.
14. Janis LR, Kravitz RD, Wagner SS. The pulsed holmium: yttrium-alu-
minum-garnet laser. Applications to ankle arthroscopy. J Clin Laser 
Med Surg 1998;16:13-20.
15. Kou L, Labrie D, Chylek P. Refractive indices of water and ice in the 
0.65- to 2.5-µm spectral range. Appl Opt 1993;32:3531-40.
16. Vuylsteke M, Van Dorpe J, Roelens J, De Bo T, Mordon S. Endov-
enous laser treatment: a morphological study in an animal model. 
Phlebology 2009;24:166-75.
17. Schmedt CG, Sroka R, Steckmeier S, Meissner OA, Babaryka G, 
Hunger K, et al. Investigation on radiofrequency and laser (980 nm) 
effects after endoluminal treatment of saphneous vein insufficiency in 
an ex-vivo model. Eur J Vasc Endovasc Surg 2006;32:318-25.
18. Proebstle TM, Sandhofer M, Kargl A, Guel D, Rother W, Knop J, et 
al. Thermal damage of the inner vein wall during endovenous laser 
treatment: key role of energy absorption by intravascular blood. Der-
matol Surg 2002;28:596-600.
19. Corcos L, Dini S, De Anna D, Marangoni O, Ferlaino E, Procacci T, 
et al. The immediate effects of endovenous diode 808-nm laser in the 
greater saphenous vein: morphologic study and clinical implications. 
J Vasc Surg 2005;41:1018-24.
20. Proebstle TM, Lehr HA, Kargl A, Espinola-Klein C, Rother W, 
Bethge S, et al. Endovenous treatment of the greater saphenous vein 
with a 940-nm diode laser: thrombotic occlusion after endolumi-
nal thermal damage by laser-generated steam bubbles. J Vasc Surg 
2002;35:729-36.
21. Bush RG, Shamma HN, Hammond K. Histological changes occur-
ring after endoluminal ablation with two diode lasers (940 and 1319 
nm) from acute changes to 4 months. Lasers Surg Med 2008;40:676-
9.
22. Kansaku R, Sakakibara N, Amano A, Endo H, Shimabukuro T, 
Suesishi M. Histological difference between pulsed wave laser and 
continuous wave laser in endovenous laser ablation. Phlebology 
2015;30:429-34.
23. Samouillan V, Dandurand J, Lacabanne C, Stella A, Gargiulo M, 
Degani a, et al. Analysis of the molecular mobility of collagen and 
elastin in safe, atheromatous and aneurysmal aortas. Pathol Biol 
2012;60:58-65.
24. Zhang Q, Huang SM, Meng LY, Wang XD, Ding JQ. Endovenous 
holmium laser treatment for varicose veins. Zhonghua Wai Ke Za Zhi 
2004;4:1244-6.
25. Blaise s, Bosson JL, Diamand JM. Ultrasound-guided sclerotherapy 
of the great saphenous vein with 1% vs 3% Polidocanol Foam: a mul-
ticentre double-blind randomised trial with 3-year follow up. Eur J 
Vasc Endovasc Surg 2010;39:779-86.
26. Ceulen RPM, Bullens-Goessens YIJM, Pi-Van De Venne SJA. Out-
comes and side effects of duplex-guided sclerotherpay in the treat-
ment of great saphenouos veins with 1% vs 3% Polidocanol Foam: 
results of a randomized controlled trial with 1-year follow up. Derma-
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going and known as LAFE (Laser-Assisted Flow En-
hancement).
Despite significant investigations in endovenous 
thermal techniques, there is still a lack of agreement re-
garding their principles of action and consequent thera-
peutic strategies.36
HOL adds a new histopathological scenario to the 
thermal induced venous wall evaluations, thus pro-
viding not only a potentially effective tumescent free 
therapeutic option, but also a deeper understanding of 
pathophysiology.
Conclusions
HOL offers a new option for tumescence-free treat-
ment of varicose veins. The device reduces saphenous 
caliber, however investigations on the topic are lacking. 
This investigation provides the first in vivo evidences 
of the effect of Hol on the endothelium and on the re-
maining vessel wall, as well as the immediate reduction 
of vein caliber. The data offer the basis for further study 
on the histologic effects durability together with inves-
tigations addressed to increasing the efficacy of present 
and future endovenous thermal devices.
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